Scinai Immunotherapeutics Ltd. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Scinai Immunotherapeutics Ltd. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2021 to Q2 2024.
  • Scinai Immunotherapeutics Ltd. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $1.01M, a 23.5% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $1.01M -$311K -23.5% Jun 30, 2024 6-K 2024-09-09
Q4 2023 $1.2M -$252K -17.4% Dec 31, 2023 6-K 2024-09-09
Q2 2023 $1.33M Jun 30, 2023 6-K/A 2023-08-18
Q1 2023 $1.43M Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $1.45M -$355K -19.6% Dec 31, 2022 20-F 2024-05-15
Q4 2021 $1.81M Dec 31, 2021 10-K 2023-04-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.